<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="26274,32874">Prolyl</z:chebi> hydroxylase activity in rectal mucosa was found to be significantly greater in 11 patients with <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> than in 11 control subjects with the <z:e sem="disease" ids="C0022104" disease_type="Disease or Syndrome" abbrv="IBS">irritable bowel syndrome</z:e> and 16 patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (P less than 0.005) </plain></SENT>
<SENT sid="1" pm="."><plain>Seven of the patients with <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> had a histologically <z:mpath ids='MPATH_458'>normal</z:mpath> rectum </plain></SENT>
<SENT sid="2" pm="."><plain>This abnormality in apparently <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa supports the concept that <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> is a 'continuous' disease of the gastrointestinal tract </plain></SENT>
<SENT sid="3" pm="."><plain>Although there was no significant difference in <z:chebi fb="0" ids="26274,32874">prolyl</z:chebi> hydroxylase activity between control subjects and patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, those patients with quiescent disease tended to have lower values than those with active mucosal <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="26274,32874">Prolyl</z:chebi> hydroxylase activity could not, however, be detected in the sera of either healthy control subjects or patients with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> </plain></SENT>
</text></document>